A Clinical Trial to Demonstrate the Efficacy of Cangrelor (PCI)
The primary objective of this study is to demonstrate that the efficacy of cangrelor is superior, or at least non-inferior, to that of clopidogrel in subjects requiring PCI.
Study Type: Interventional
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Treatment
Official Title: A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects Who Require Percutaneous Coronary Intervention (PCI).
Study Start Date: April 2006
Study Completion Date: June 2010
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
- Experimental: Cangrelor
- Active Comparator: Clopidogrel
Related Journal: Platelet inhibition with cangrelor in patients undergoing PCI.
|Study start date||2006-04-01|